Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).
ο»Ώ

NDAQ:MNMD - Post by User

Comment by Let5MakeMoneyon Jan 16, 2021 3:27pm
215 Views
Post# 32313839

RE:RED LIGHT HOLLAND $TRIP πŸ„πŸ„πŸ„πŸ„πŸ„

RE:RED LIGHT HOLLAND $TRIP πŸ„πŸ„πŸ„πŸ„πŸ„No offense to anyone who is an investor in TRIP, as I am as well, but did this video make anyone else feel like these guys were on mushrooms when they did this video? Honestly, I understand they are trying to have fun but if this was supposed to be a serious video about why someone should invest in this company, I feel like they really need to work on their PR tactics. And who is the reporter? He's an absolute joke if you ask me. They need to forget using wall street reporter as a communication outlet in my opinion.
<< Previous
Bullboard Posts
Next >>